Status:
UNKNOWN
Inflammation and Coagulation Factors for Predicting Cerebral Edema After SAH
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions:
Inflammation
Coagulation and Hemorrhagic Disorders
Eligibility:
All Genders
20-80 years
Brief Summary
Explore the role of Inflammation and coagulation factors in cerebrospinal fluid for predicting persistent cerebral edema after subarachnoid hemorrhage
Eligibility Criteria
Inclusion
- Subarachnoid hemorrhage patients admitted to our neurosurgery department with modified Fisher Scale 3-4, with a confirmed radiographic diagnosis.
Exclusion
- Angiogram-negative patients, patients with a history of trauma or previous brain injury (stroke, hemorrhage, surgery et al. which left associated chronic changes on CT), arteriovenous malformation, radiological data lost, accompany with serious comorbidities before subarachnoid hemorrhage onset (such as coagulation defects, uncontrollable hypertension, and arrhythmia et.al.), initial radiological data performed more than 3 days after SAH onset
Key Trial Info
Start Date :
August 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06009016
Start Date
August 1 2022
End Date
August 1 2024
Last Update
August 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Second affiliated hospital of Zhejiang University, School of Medicine
Hangzhou, Zhejiang, China, 310000